Chison Medical Technologies Co

Chison Medical Technologies Co Quick Ratio

The Quick Ratio (Acid Test) of Chison Medical Technologies Co (688358.SS) as of Oct 31, 2026 is 0.09. In the previous year, Quick Ratio (Acid Test) was 7.04 — a change of -98.68% (lower).

Quick Ratio

0.09

YoY

-98.68%

Last updated:

Quick Ratio (Acid Test) of Chison Medical Technologies Co is 2025 0.09 . Quick Ratio (Acid Test) of Chison Medical Technologies Co was 2024 7.04 . It decreases by -98.68% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Chison Medical Technologies Co Stock analysis

What does Chison Medical Technologies Co do? Chison Medical Technologies Co Ltd generates revenue through the research and development, manufacturing, and sales of ultrasonic medical imaging equipment. The company develops core components such as color ultrasound probes, image processing algorithms, and image analysis software, which are integrated into complete color ultrasound machines. Its primary customers include domestic and foreign medical institutions, scientific research institutions, and strategic partners. The firm targets departments within hospitals such as ultrasound, anesthesiology, catheterization, obstetrics and gynecology, emergency, tumor surgery, breast surgery, nephrology, gastroenterology, and pain management. The company focuses on both domestic and overseas markets, leveraging its expertise in ultrasound technology to serve a wide range of healthcare settings. By providing comprehensive solutions that include equipment and technology development services, Chison Medical Technologies supports medical professionals in various specialties. Its product portfolio is designed to meet the specific needs of different hospital departments, enhancing diagnostic capabilities and patient care. Chison Medical Technologies Co Ltd’s business model centers on delivering high-quality ultrasound imaging solutions through continuous innovation in core components and software. The firm’s strategic partnerships with medical institutions and research organizations drive demand for its advanced imaging equipment. This approach ensures consistent revenue streams from both established and emerging healthcare markets. Chison Medical Technologies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Chison Medical Technologies Co stock

Quick Ratio (Acid Test) of Chison Medical Technologies Co is 0.09 in 2025.

Quick Ratio (Acid Test) of Chison Medical Technologies Co changed from 7.04 to 0.09, representing a -98.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Chison Medical Technologies Co since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Chison Medical Technologies Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Chison Medical Technologies Co

All Key Metrics — Chison Medical Technologies Co